RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.
about
The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21.Identification of DEP domain-containing proteins by a machine learning method and experimental analysis of their expression in human HCC tissues.Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease
P2860
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.
@en
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.
@nl
type
label
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.
@en
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.
@nl
prefLabel
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.
@en
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.
@nl
P2860
P1433
P1476
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer
@en
P2093
Bandana Chakravarti
Katelin E Ahlers
P2860
P2888
P304
P356
10.1208/S12248-016-9899-9
P407
P50
P577
2016-03-22T00:00:00Z
P6179
1015446048